NHO Kinki Chuo Chest Medical Center

Recent papers from NHO Kinki Chuo Chest Medical Center

1. Non‐Pharmacological Psychosomatic Approaches to Patients With Atopic Dermatitis: A Delphi Consensus of Expert Opinions in JapanThe Journal of Dermatology · 2026
2. Clinical Outcomes and Prognostic Factors of ABCP Therapy in EGFR-mutated NSCLC in the Osimertinib EraAnticancer Research · 2026
3. Molgramostim improves exercise distance and duration in autoimmune pulmonary alveolar proteinosis: exploratory IMPALA-2 trial dataAnnals of the American Thoracic Society · 2026
4. Nintedanib for progressive pulmonary fibrosis associated with sarcoidosis: a retrospective preliminary observational reportRespiratory Investigation · 2026
5. Non-elderly asthma phenotypes and blood eosinophils are associated with clinical outcomes in elderly asthmaBMC Pulmonary Medicine · 2026
6. The 2025 revision of JPOS/JASCC clinical guidelines for delirium in adult patients with cancer: a summary of recommendationsJapanese Journal of Clinical Oncology · 2026
7. Is Acute Exacerbation of Terminal Restlessness Predictable Using Continuous Monitoring with a Sheet-Type Nonwearable Sensor Device?Journal of Palliative Medicine · 2026
8. Treatment strategies of palliative care and psycho-oncology specialists for patients with both pain and delirium: a nationwide surveyScientific Reports · 2026
9. Real-world outcomes of unresected non-small cell lung cancer following neoadjuvant chemoimmunotherapyGeneral Thoracic and Cardiovascular Surgery · 2026
10. Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialAmerican Journal of Respiratory and Critical Care Medicine · 2026
11. Nonpharmacological interventions for preventing delirium in adult patients with cancer: a systematic review and meta-analysisSupportive Care in Cancer · 2026
12. Palliative Care Team Involvement Is Associated with Changes in Nutrition Impact Symptoms and Eating-Related Distress in Patients with Advanced Cancer: A Multicenter Prospective Observational StudyNutrients · 2026
13. Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosisNature Communications · 2026
14. Real-world comparison of carboplatin–pemetrexed–bevacizumab versus chemo-immunotherapy in EGFR-mutated lung cancer.Journal of Clinical Oncology · 2026
15. Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancerEuropean Journal of Cancer · 2026
16. Efficacy of a structured rehabilitation program for patients with terminal cancer: A multicenter randomized controlled trialCancer · 2026
17. Ramelteon for prevention of postoperative delirium in elderly cancer patients: A randomized, double-blind, placebo-controlled multicenter trial, JORTC-PON02/J-SUPPORT2103/NCCH2103.Journal of Clinical Oncology · 2026
18. Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non‐Squamous Non‐Small Cell Lung Cancer: A Multicenter Retrospective StudyThoracic Cancer · 2026
19. Real-World Comparison of Carboplatin–Pemetrexed–Bevacizumab versus Chemo-Immunotherapy in EGFR-Mutated Lung CancerInternational Journal of Lung Cancer · 2026
20. Phase III study of multidisciplinary therapy combining local ablative therapy with immune-checkpoint inhibitors for patients with synchronous oligometastatic NSCLC (J-OLIGO: WJOG20924L).Journal of Clinical Oncology · 2026